Studio Investment Management LLC Has $1.29 Million Stock Position in Aflac Incorporated (NYSE:AFL)

Studio Investment Management LLC reduced its position in Aflac Incorporated (NYSE:AFL) by 9.6% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 11,514 shares of the financial services provider’s stock after selling 1,219 shares during the period. Studio Investment Management LLC’s holdings in Aflac were worth $1,287,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Spinnaker Trust boosted its position in shares of Aflac by 2.7% in the 3rd quarter. Spinnaker Trust now owns 3,620 shares of the financial services provider’s stock worth $405,000 after purchasing an additional 95 shares during the last quarter. Secure Asset Management LLC boosted its position in shares of Aflac by 1.0% in the 3rd quarter. Secure Asset Management LLC now owns 9,783 shares of the financial services provider’s stock worth $1,094,000 after purchasing an additional 96 shares during the last quarter. Ascent Group LLC boosted its position in shares of Aflac by 0.6% in the 2nd quarter. Ascent Group LLC now owns 17,231 shares of the financial services provider’s stock worth $1,539,000 after purchasing an additional 99 shares during the last quarter. Ieq Capital LLC boosted its position in shares of Aflac by 0.5% in the 2nd quarter. Ieq Capital LLC now owns 21,775 shares of the financial services provider’s stock worth $1,945,000 after purchasing an additional 101 shares during the last quarter. Finally, New Century Financial Group LLC boosted its position in shares of Aflac by 2.5% in the 3rd quarter. New Century Financial Group LLC now owns 4,198 shares of the financial services provider’s stock worth $469,000 after purchasing an additional 101 shares during the last quarter. 67.44% of the stock is owned by institutional investors and hedge funds.

Aflac Stock Performance

Shares of Aflac stock opened at $112.09 on Friday. The firm has a market cap of $62.27 billion, a price-to-earnings ratio of 16.88, a price-to-earnings-growth ratio of 2.14 and a beta of 0.96. The stock’s 50-day moving average is $110.66 and its 200-day moving average is $100.24. Aflac Incorporated has a one year low of $75.07 and a one year high of $115.50. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.08 and a quick ratio of 0.08.

Aflac (NYSE:AFL) last released its earnings results on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.69 by $0.47. The business had revenue of $2.95 billion for the quarter, compared to the consensus estimate of $4.30 billion. Aflac had a return on equity of 16.34% and a net margin of 22.02%. Aflac’s quarterly revenue was down 40.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.84 earnings per share. Equities analysts predict that Aflac Incorporated will post 7.22 earnings per share for the current fiscal year.

Aflac Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Wednesday, November 20th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.78%. The ex-dividend date is Wednesday, November 20th. Aflac’s dividend payout ratio (DPR) is presently 30.12%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the company. Bank of America raised their price target on Aflac from $115.00 to $124.00 and gave the stock a “buy” rating in a research report on Thursday, October 10th. Truist Financial lifted their target price on Aflac from $100.00 to $105.00 and gave the stock a “hold” rating in a report on Friday, November 1st. Morgan Stanley lifted their target price on Aflac from $91.00 to $98.00 and gave the stock an “equal weight” rating in a report on Monday, August 19th. Barclays started coverage on Aflac in a report on Wednesday, September 4th. They set an “underweight” rating and a $96.00 target price on the stock. Finally, Evercore ISI lifted their target price on Aflac from $84.00 to $90.00 and gave the stock an “underperform” rating in a report on Thursday, September 26th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $97.93.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.